Organization Profile

You just read:

BELLUS Health announces update on the Phase III trial for KIACTA™ in AA amyloidosis presented at the XIII International Symposium on Amyloidosis

News provided by

BELLUS HEALTH INC.

May 10, 2012, 08:00 ET